Vu Milkie, Yeom Jimin, Trinh Duy, Gou Jane, Hong Timothy, Zaheeruddin Marym, Bishop-Royse Jessica, Hartstein Madison, Spring Bonnie, Moskowitz David, Doan Anh, Martin Molly
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N. Lakeshore Drive, Suite 1400, Chicago, IL, 60611, USA.
School of Public and International Affairs, Princeton University, Robertson Hall, Princeton, NJ, 08540, USA.
J Community Health. 2025 May 7. doi: 10.1007/s10900-025-01472-8.
In the U.S., responses to the rollout of COVID-19 vaccine varied widely, with contrasting perceptions of the vaccine. We aimed to characterize distinct groups of respondents regarding COVID-19 vaccine perceptions.
Data came from the 2021-2023 Common Survey (n = 852), collected in Chicago using a community-based participatory approach focusing on communities with low COVID-19 vaccination. Participants answered eight questions about vaccine-related perceptions. We conducted a latent class analysis in R.
The sample included 623 female participants (73.1%), 482 Black participants (56.6%), 259 Hispanic/Latino(a) participants (30.4%), 26 Asian participants (3.1%), and 261 participants with a college degree (30.6%). In a four-class model, Class 1 (skeptic) included 153 participants (18.0%) with low confidence in vaccine safety, effectiveness, and potential to get life back to normal. Class 2 (uncertain) included 163 participants (19.1%) who mostly indicated uncertainty. Class 3 (support with concerns) included 266 participants (31.2%) who recognized many vaccine benefits but also had concerns about its rapid development and "not being studied in people like me." Class 4 (pro-vaccine) included 270 participants (31.7%) with high confidence in vaccine safety and effectiveness and social approval of vaccination. Interestingly, both the skeptic and pro-vaccine groups had somewhat similar agreement with the statement "not enough information on COVID vaccine interaction." Class assignments varied by sociodemographic characteristics. Socioeconomic hardships were associated with a lower likelihood of being in the "pro-vaccine" group.
Given the distinct classes of vaccine beliefs, tailored public health messaging is needed to enhance vaccine confidence and uptake.
在美国,对新冠疫苗推出的反应差异很大,对疫苗的看法也截然不同。我们旨在描述在新冠疫苗看法方面不同的受访者群体。
数据来自2021 - 2023年的普通调查(n = 852),该调查在芝加哥采用基于社区的参与式方法收集,重点关注新冠疫苗接种率低的社区。参与者回答了八个关于疫苗相关看法的问题。我们在R语言中进行了潜在类别分析。
样本包括623名女性参与者(73.1%)、482名黑人参与者(56.6%)、259名西班牙裔/拉丁裔参与者(30.4%)、26名亚洲参与者(3.1%)以及261名拥有大学学位的参与者(30.6%)。在一个四类模型中,第1类(怀疑者)包括153名参与者(18.0%),他们对疫苗的安全性、有效性以及使生活恢复正常的潜力信心较低。第2类(不确定者)包括163名参与者(19.1%),他们大多表示不确定。第3类(有担忧的支持者)包括266名参与者(占31.2%),他们认识到疫苗的许多益处,但也对其快速研发以及“没有在像我这样的人群中进行研究”表示担忧。第4类(支持疫苗者)包括270名参与者(占31.7%),他们对疫苗的安全性和有效性高度信任,并且在社会层面认可接种疫苗。有趣的是,怀疑者和支持疫苗者群体对“关于新冠疫苗相互作用的信息不足”这一说法的认同程度有些相似。类别分配因社会人口学特征而异。社会经济困难与属于“支持疫苗”群体的可能性较低相关。
鉴于疫苗信念的不同类别,需要针对性的公共卫生信息传递来增强疫苗信心并提高接种率。